Lifestyle changes linked to better outcomes after peripheral intervention

Findings from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium registry show dramatic underuse of basic medical therapy

2012-12-21

(Press-News.org) ANN ARBOR, Mich. – Patients who quit smoking and took an aspirin and statin before undergoing treatment for blocked leg arteries were less likely to suffer a complication six months later, according to new research led by the University of Michigan Cardiovascular Center.

But few patients made the lifestyle changes and were on recommended medical therapy that can relieve leg pain and cramping associated with peripheral arterial disease, or PAD.

The registry findings were published online ahead of print in Circulation: Cardiovascular Interventions and reveal a dramatic underuse of basic medical treatment for PAD.

PAD is on the rise as people age and conditions such as diabetes, high blood pressure and obesity affect circulation. Peripheral vascular interventions, such as angioplasty, improves blood flow, specifically to the legs.

But before PVI, more than half of patients studied failed to receive minimal medical therapy, meaning that the patient quit smoking and took an aspirin and a statin -- drugs that can reduce blood clots and improve blood flow.

Even the doctors treating the patients for their blockages didn't always ensure that their patients went home from the hospital with a prescription.

At admission, 46.7 of patients were on aspirin, a statin and did not smoke; at discharge 71 percent were on both drugs and either did not smoke or still smoked but had smoking cessation counseling.

"The modest improvement in statin prescription before patients were discharged signifies a missed opportunity to provide a life-saving intervention for PAD patients," says lead study author P. Michael Grossman, M.D., an interventional cardiologist at the University of Michigan Cardiovascular Center.

Users of both aspirin and statins had a lower incidence of peripheral events such as repeat PVI, limb salvage surgery and amputation – 7 percent compared to 15.8 percent.

The study included 1,357 patients identified in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium Peripheral Vascular Intervention database. The BMC2 PVI registry includes patients from Michigan hospitals who underwent an intervention for treatment of PAD. Patients are often referred for PVI to manage leg pain and cramping – a symptom that doctors call claudication.

More study is needed to determine reasons for the lack of medical therapy. Meanwhile the underuse of medical treatment known to reduce symptoms of claudication and adverse events is a "pressing quality gap," authors say.

"Although a considerable effort has been focused on the impact of guideline adherence in patients with heart attack and heart failure, there are currently no such national programs focused on patients with PAD," Grossman says.

"In Michigan, BMC2 PVI is actively working to improve the medical therapy and outcomes of patients with PAD who undergo revascularization procedures. Data such as this have allowed us to recognize the issues and give us the tools necessary to impact change," he says.

### Additional authors: Amer K. Ardati, M.D.; Samuel R. Kaufman, MA; and Hitinder S. Gurm, M.D., of the University of Michigan and Herbert D. Aronow, M.D., M.P.H., of St. Joseph Mercy Hospital; Timothy J. Nypaver, M.D, of Henry Ford Health System; and Paul G. Bove, M.D., of William Beaumont Health System.

Reference: "The Quality and Impact of Risk Factor Control in Patients with Stable Claudication Presenting for Peripheral Vascular Interventions," Circulation: Cardiovascular Intervention, Dec. 11, 2012, doi:10.1161.

Funding: Blue Cross Blue Shield of Michigan

On the web University of Michigan Cardiovascular Center
www.uofmhealth.org/heart END

ELSE PRESS RELEASES FROM THIS DATE:

Study shows heart calcium scan predictive of diabetes-related death from cardiovascular disease

2012-12-21

WINSTON-SALEM, N.C. – Dec. 20, 2012 – People with Type 2 diabetes have two to four times the risk of cardiovascular disease compared to people without the disease. The best way for doctors to predict which diabetes patients are at the greatest risk for heart disease is to use a coronary artery calcium (CAC) test in addition to the most commonly used assessment tool, according to researchers at Wake Forest Baptist Medical Center. Current medical guidelines recommend treating all diabetes patients as high risk, but the Wake Forest Baptist study found that CAC can identify ...

Scripps Florida scientists create new approach to destroy disease-associated RNAs in cells

2012-12-21

JUPITER, FL, December 20, 2012 – Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a new approach to alter the function of RNA in living cells by designing molecules that recognize and disable RNA targets. As a proof of principle, in the new study the team designed a molecule that disabled the RNA causing myotonic dystrophy. The study, published online ahead of print on December 20, 2012 by the journal Angewandte Chemie, reports the creation of small molecules that recognize disease-associated RNAs, targeting them for destruction. ...

WCS applauds Dept. of Interior plan balancing conservation and energy development in NPR-A

2012-12-21

The Wildlife Conservation Society (WCS) lauded U.S. Secretary of the Interior Ken Salazars announcement of a final management plan for the National Petroleum Reserve-Alaska (NPR-A) that balances wildlife conservation and energy development in the biggest public landscape in the country. The Integrated Activity Plan and Final Environmental Impact Statement (Final IAP/EIS) issued today by the Bureau of Land Management is the first comprehensive land management plan ever developed for the NPR-A. By protecting extensive coastal plain habitat around Teshekpuk Lake, and the ...

Black piranha, megapiranha have most powerful bites of fish living or extinct, finds GW researcher

2012-12-21

WASHINGTON— The black piranha and the extinct giant piranha, or megapiranha, have the most powerful bites of carnivorous fishes, living or extinct, once body size is taken into account, finds researchers in a paper recently published in Scientific Reports. The research paper, Mega-Bites: Extreme jaw forces of living and extinct piranhas, highlights the piranhas' specialized jaw morphology, which allows them to attack and bite chunks out of much larger prey. Guillermo Ortí, the George Washington University Louis Weintraub Professor of Biology in the Columbian College of ...

Transplanted genetically-modified adipose cells offer potential therapy for liver diseases

2012-12-21

Putnam Valley, NY. (Dec. 20, 2012) – Using mesenchymal stromal cells derived from adipose (fat) tissues, genetically modified to express a bioluminescent marker, researchers in Italy have tracked cells after transplantation. The cells were followed from their injection into the spleen of mice modeling liver disease, to their characterization as "hepatic precursors," and to their subsequent migration through the spleen before engrafting at regenerating sites in the liver by bioluminescent imaging. Their study is described in a recent issue of Cell Transplantation (21:9), ...

Cell Transplantation study investigates fate and function of cells transplanted to the CNS

2012-12-21

Putnam Valley, NY. (Dec. 20, 2012) – When different types of cells are transplanted with the intent of having them aid in repairing central nervous system (CNS) trauma, what is the fate and function of those cells? A Belgian research team carried out research aimed at answering this question by determining how five varieties of cells - neural stem cells, mouse embryonic fibroblasts, dendritic cells, bone marrow mononuclear cells (BMMNCs) and splenocytes - functioned and survived after transplantation in the CNS. Their study is published in a recent issue of Cell Transplantation ...

Study reports iron oxide nanoparticles effective for labeling human endothelial cells

2012-12-21

Putnam Valley, NY. (Dec. 20, 2012) – A team of researchers from three medical institutions in Guangzhou, China, have found that iron oxide nanoparticles (INOPS) are a useful contrast agent for in vivo magnetic resonance tracking of transplanted human endothelial cells. However, the impact of INOPS on the cells varies with a number of factors including the INOPS load. They found that the percentage of iron-labeled cells was significantly lower after 48 hours post-transplantation than at 24 hours post-transplantation. They also found that high INOPS concentration can affect ...

Doing the math for how songbirds learn to sing

2012-12-21

Scientists studying how songbirds stay on key have developed a statistical explanation for why some things are harder for the brain to learn than others. "We've built the first mathematical model that uses a bird's previous sensorimotor experience to predict its ability to learn," says Emory biologist Samuel Sober. "We hope it will help us understand the math of learning in other species, including humans." Sober conducted the research with physiologist Michael Brainard of the University of California, San Francisco. Their results, showing that adult birds correct ...

Young scientist helps identify cause of widespread eye disease

2012-12-21

Branch retinal vein occlusion – blockage of the blood vessels that channel blood from the retina – is a common eye disease. A type of blood clot in the eye, the disease causes reduced vision, and people with the disease also typically have an increased risk of hypertension, diabetes and other serious conditions. A young scientist from the University of Copenhagen has made a significant contribution to finding the cause of the disease. Mette Bertelsen and her colleagues photographically verified the diagnosis of branch retinal vein occlusion in 1168 people. A team of ...

NJ Association of Verismo Opera to Hold Auditions for Boys to Perform in Gianni Schicchi

2012-12-21

The NJ Association of Verismo Opera is known for developing the stars of tomorrow. Artistic Director Lucine Amara announces boys, nine to eleven years of age, with a soprano voice are invited to audition for the role Gherardino in the grand, professional opera company's production of Giacomo Puccini's Gianni Schicchi that will be performed on Sunday, April 21 at the Bergen Performing Arts Center (bergenPAC) in Englewood, New Jersey. Open auditions will be held on January 7, 2013 from 4-7 p.m. at the bergenPAC in the Cabaret Room, 30 North Van Brunt Street. The application ...